Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.


Britain's Prince William calls for optimism on environment at EarthShot Prize event
Typhoon Kalmaegi death toll hits 114 in Philippines; heads to Vietnam
Investigators find 'black boxes' from UPS plane crash that killed at least 12
Zohran Mamdani wins NYC mayoral race, capping meteoric rise
